دورية أكاديمية

Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial

التفاصيل البيبلوغرافية
العنوان: Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial
المؤلفون: Cowan, Mathew, Swetzig, Wendy M., Adorno-Cruz, Valery, Pineda, Mario J., Neubauer, Nikki L., Berry, Emily, Lurain, John R., Shahabi, Shohreh, Taiym, Deanna, Nelson, Valerie, O'Shea, Kaitlyn Lucrezia, Kocherginsky, Masha, Matei, Daniela
المصدر: Gynecologic Oncology ; volume 163, issue 1, page 57-63 ; ISSN 0090-8258
بيانات النشر: Elsevier BV
سنة النشر: 2021
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Obstetrics and Gynecology, Oncology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.ygyno.2021.08.005
الإتاحة: https://doi.org/10.1016/j.ygyno.2021.08.005Test
https://api.elsevier.com/content/article/PII:S0090825821006508?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0090825821006508?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/
رقم الانضمام: edsbas.F4C865D7
قاعدة البيانات: BASE